Product Name
|
IDRA-21
|
CAS NO.
|
22503-72-6
|
MF
|
C8H9ClN2O2S
|
MW
|
232.687
|
Appearance
|
White Powder
|
Purity
|
99% min
|
Density
|
1.4±0.1 g/cm3
|
Boiling point
|
405.1±55.0 °C at 760 mmHg
|
Application
|
Pharmaceutical Intermediates
|
Grade
|
Medicine Grade
|
Sample
|
Available
|
MOQ
|
1KG
|
Place of origin
|
China(Hubei)
|
Delivery time
|
With in 7~10 days after payment
|
Description
IDRA-21 shows nootropiceffects in animal studies, significantly improving learning and memory. It is around 10-30x more potent than aniracetam in reversing cognitive deficits induced by alprazolamorscopolamine, and produces sustained effects lasting for up to three days after a single dose. The mechanism for this action is thought to be through promoting the induction of long-term potentiationbetween synapses in the brain.
Function
1.IDRA-21 powder can increases in cognitionIncreased Task Accuracy.
2.
IDRA-21 powder can i
ncreases in Short Term Memory.
3.
IDRA-21 powder have p
otential Therapeutic Effects On Schizophrenia.
4.
IDRA-21 powder have p
otental Therapeutic Effects On Depression.
5.
IDRA-21 powder have n
europrotection.
6.
IDRA-21 powder have b
enefits Against Alp-induced Cognitive Deficit.
Application
IDRA-21
is a benzothiadiazine derivative, inhibits AMPA receptor desensitization and enhances cognition by a related mechanism.It's a positive allosteric modulator of glutamate AMPA receptors (1,2,3,4). It is able to increase excitatory synaptic strength by inhibiting AMPA receptor desensitization. Demonstrates nootropic effects in animal studies, significantly improving learning and memory.
Our Company